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Abstract
Background: Modern resuscitation strategies following haemorrhagic shock are influenced by global haemodynamic
parameters such as blood pressure and cardiac output. Microcirculatory dysfunction in this context may persist
even after restoration of satisfactory global parameters. Additional monitoring of the microcirculatory function
may therefore be warranted in order to facilitate goal-directed therapy at a tissue oxygenation level. Although
such a phenomenon is recognised in the case of sepsis, clinical evidence regarding the behaviour of the
microcirculation following the delivery of resuscitation fluids after haemorrhagic shock is sparse. A summation
of the current state of pre-clinical evidence is justified in order to direct avenues for future clinical research.
Methods/design: Systematic review methodology will be utilised in order to identify relevant studies, assess for
bias, and extract data for analysis. Medical databases will be searched to find pre-clinical studies that monitor the
microcirculatory function following haemorrhagic shock and subsequent fluid resuscitation. Different fluid types
(e.g. blood products, crystalloid, and colloid fluids) will be compared. The search strategy will combine terms for
the animal model, resuscitation fluid, and microcirculatory parameters. Randomised and non-randomised
experiments, as well as case series, will be eligible for inclusion. Specific quality assessment tools for pre-clinical
research will be used depending on study design. A combination of narrative and meta-analysis techniques will
be used for the synthesis of data.
Discussion: The choice of type, sequence, and quantity of resuscitation fluid following haemorrhagic shock is
controversial, and the optimal strategy for restoration of microcirculatory function is yet unknown. A detailed
examination of pre-clinical data regarding the microcirculation is timely and will enable a focussed approach
to clinical research for the improvement of resuscitation following haemorrhagic shock.
Systematic review registration: Collaborative Approach to Meta Analysis and Review of Animal Data from
Experimental Studies (CAMARADES)
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Background
Global measures of circulatory function such as cardiac
output have long been used in the targeted resuscita-
tion of trauma casualties, with the focus on maintaining
parameters of measurements such as blood pressure
and heart rate. Such parameters are really only surrogate
markers of tissue perfusion since they do not directly de-
scribe the transfer of oxygen and nutrients between the
circulation and tissues but instead concern more global
transfer of blood around the body. Since shock can be de-
scribed as inadequate oxygenation of tissues due to circula-
tory failure, it may be more appropriate to examine the
end vessels that directly participate in this process—the
microcirculation. The microcirculation can be described
as the network of small vessels such as capillaries that per-
form the physiological functions of oxygen delivery and
respiratory substrates to the cells. Therefore, the micro-
circulation may represent the effectiveness of oxygen
delivery better than the macro-circulation.
There is a clinical correlation between microcircula-
tory dysfunction and poorer patient outcomes in sepsis
[1], and early pilot data has suggested the same for
patients with traumatic haemorrhagic shock [2]. Out-
comes appear to be improved when goal directed treat-
ment is aimed at the restoration of the microcirculation in
the case of sepsis [3] and after major surgery [4]. Some pa-
tients may have critically impaired microcirculation even
when the more global measurements such as cardiac
output appear to be well controlled, and therefore,
targeted resuscitation might be improved with emphasis
on the microcirculation rather than more conventional
and commonly measured global markers of haemodynam-
ics. If such a phenomenon proves true for haemorrhagic
shock, then a greater understanding of microcirculatory
changes following delivery of resuscitation fluids may
open channels for future therapeutic trials into goal
directed therapy for trauma patients.
So far, there has been no systematic review of pre-clinical
data with regard to resuscitation fluids and the microcircu-
lation. The Microshock study (ClinicalTrials.gov identifier:
NCT02111109) aims to characterise the microcirculatory
changes in patients with traumatic haemorrhagic
shock, but the specific effects of resuscitative fluids
on the microcirculation is unknown. It is timely to
conduct a systematic review to summarise the available
data in the published pre-clinical literature regarding the
impact of resuscitation fluids on the microcirculatory
function following haemorrhagic shock. This will provide
exploratory data to generate new hypotheses that
might direct further avenues for clinical research.
Methods
This protocol was written using the SYRCLE format [5].
Standardised systematic review methodology will be
utilised according to the Cochrane handbook [6] and
reported according to the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines [7]. Where relevant, reporting guidelines
developed for systematic reviews of pre-clinical studies
will also be used [8].
Research questions
This is the first review to examine the impact of different
fluid resuscitation techniques on the physical structure
and function of the microcirculation in animal models.
The following questions will be addressed:
 What is the impact of intravascular fluid
resuscitation on the microcirculation following
haemorrhagic shock, compared to haemorrhagic
shock alone?
 Which type of fluid has the most impact on the
microcirculation following haemorrhagic shock,
compared to haemorrhagic shock alone?
 Compared to crystalloid fluid, which type of fluid
has more of an impact on the microcirculation:
colloid or packed red blood cells (PRBCs)?
Disease of interest
The pathophysiological process of interest is haemorrhagic
shock.
Population studied
This systematic review will examine all animal models of
haemorrhagic shock, regardless of mode of haemorrhage,
species, or size of animal.
Intervention
Exploratory assessment of relevant studies has revealed
that there are multiple interventions of interest. For
example studies may test (i) blood products versus
crystalloids versus haemorrhage alone or (ii) crystalloids
versus colloids versus haemorrhage alone in the resuscita-
tion of animals following haemorrhagic shock.
In order to address this heterogeneity, and still pro-
vide an informative summary of all intravascular fluid
resuscitation techniques, each individual intervention
will analysed as subgroups to test the individual as
well as summary effects. This will be in the form of
meta-analytical techniques when there are sufficient
numbers of studies with homogenous design and, in more
qualitative terms, when studies are heterogeneous and
small in number. The following interventions are deter-
mined a priori:
a. Primary intervention: PRBCs
b. Secondary interventions: whole blood; plasma;
colloids (e.g. 10 % hydroxyethyl starch, albumin);
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crystalloids (e.g., Ringer’s lactate, normal saline);
modified blood components (e.g. PRBC + nitrites
or RRx-001)
PRBC has been chosen as the primary intervention
because it is the most likely intravascular resuscitative
measure delivered in a clinical setting for patients who
have suffered traumatic haemorrhagic shock.
Control population
The control population for meta-analysis will be animals
that have undergone the haemorrhagic shock protocol
alone, with no intervention. Studies comparing different
types of fluids but without haemorrhagic shock alone
will be included but analysed separately. Non-controlled
studies will also be eligible for inclusion but for descrip-
tive analysis only.
Outcome measures
Preliminary searches have shown that there are multiple
microcirculatory physical parameters that have been
reported in experimental studies of fluid resuscitation
following haemorrhagic shock. The following outcome
measures (measured at any anatomical position, provided
that it is in the microcirculatory vessels) will be used:
a. Primary outcome: flow rate (nL/s)
b. Secondary outcomes: vessel diameter (μm);
functional capillary density (%); red blood cell
velocity (mm/s); shear rate (s−1); glycocalyx
thickness (μm); permeability (%); proportion of
perfused vessels (%)
Since this review is primarily concerned with the patho-
physiology of the microcirculation, clinical and prognostic
factors of the animal models will not be examined in this
review. This is because the animals are likely to be eutha-
nized before longer-term data is available.
Search and study identification
The following sources will be searched for primary studies:
EMBASE and Medline (via OVID SP) and SCOPUS. Be-
fore starting this review, scoping searches were undertaken
to identify any existing systematic reviews of the impact of
resuscitative fluids on the microcirculatory changes during
haemorrhagic shock and to gauge the number and type of
relevant primary studies. No systematic reviews were iden-
tified, but there are a number of pre-clinical studies.
The systematic search will be undertaken using a
combination of text and MeSH terms relating to the
intervention (“bleed”, “transfusion”, “fluid resuscitation”,
“colloid”, “red blood cells”), to the condition (e.g. “haem-
orrhage”, “trauma”, “injury”, “shock”), and to the micro-
circulation (e.g. “microcirculation”, “endothelium”,
“capillary”); see Additional file 1 for a sample search
strategy in MEDLINE. The search strategies will be
broad in order to capture any study that has explored
resuscitation fluids and microcirculatory changes in the
context of haemorrhagic shock, regardless of study
design, study subjects, method of assessment, or out-
comes reported. There will be no language restrictions
or restrictions by publication type. Citations will be
collated using EndNote reference management software
(V.X7, Thomson Reuters). Reference lists of included




All titles and abstracts will be screened for eligibility
by two independent reviewers, and full texts obtained
for potentially relevant studies. References from these
full texts will be further screened for potentially rele-
vant papers using pre-defined selection criteria. The
study selection process will be illustrated using a
PRISMA flow diagram.
Reviewers and discrepancies
All titles and abstracts will be screened for eligibility
by two authors. Discrepancy between reviewers will
be resolved by discussion or by referring to a third
reviewer.
Inclusion and exclusion criteria
Type of study (design)
Any pre-clinical study may be eligible for inclusion if
it reports data regarding the impact of resuscitation
fluids on the microcirculation in an animal model
that has been subject to any form of haemorrhagic
shock. These may include randomised controlled trials
(e.g. where microcirculatory dynamics are an outcome
measure to assess the effect of alternative resuscitative
fluid interventions for haemorrhagic shock) or pro-
spective case series or controlled studies (e.g. where
haemorrhagic shock is induced in animals and effects
on the microcirculation monitored following fluid
resuscitation). Single case reports, conference proceed-
ings, abstracts, and letters to the editor will be
screened but will be subsequently excluded if essential
methodological information is missing.
Type of animal/population
All animal models of haemorrhagic shock are eligible
for inclusion, regardless of gender, age, or species.
Knockout animals and those with co-morbidities are
eligible for inclusion but will be analysed separately
(i.e. not pooled with wild-type or healthy animals).
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Type of intervention
Animals must receive intravascular fluid of any volume
in order to be eligible for inclusion, which may include
any of whole blood, packed red blood cells, plasma,
crystalloid fluid, colloid fluid, altered blood products,
or a combination of these. The fluid must be delivered
after a phase of haemorrhagic shock and subsequent
microcirculatory measurements taken following its
delivery. Studies that report data regarding the micro-
circulation will be excluded if this is not in the con-
text of haemorrhagic shock (e.g. studies that only
discuss sepsis will be excluded). Studies reporting
both cases of sepsis and haemorrhagic shock will be
included providing data can be separated for haemor-
rhagic shock only.
Outcome measures
Studies are included if they record at least one physical
parameter of the microcirculation following a phase
of haemorrhagic shock. Studies that only report
microcirculatory function (such as oxygen pressures)
will be excluded unless they also report the physical
properties.
Restrictions
There are no language restrictions. Where necessary,
translation (full/part) of non-English language articles
will be undertaken. No publication date restriction will
be applied. Although the pathophysiological process of
interest is traumatic haemorrhagic shock, any model of
haemorrhagic shock will be eligible for inclusion. This
includes models of obstetric haemorrhage in pregnant
animals. Where studies are found that also model
trauma (such as blast or penetrating injury), these will
be highlighted and analysed separately.
Exclusion criteria by stage
Exclusion of type of intervention and outcome mea-
sures will be conducted during title/abstract screening.
Any further exclusion will be made following the full
text screening.
Study characteristics to be extracted
Data from all relevant full texts will be extracted
using a standardised, piloted data extraction form.
Data extraction will be performed by one reviewer
and checked by a second. Study authors will be
contacted where information in the published articles
is missing or unclear.
Study ID
The first author and year will be extracted to identify
individual studies. Where multiple studies have the same
author and year, the month of publication will also be
extracted.
Study design characteristics
Design and methodology of individual studies will be
extracted, including type of study, sample size, experi-
mental groups, animal housing, and length of follow-up.
Animal model characteristics
Species of animal as well as age, strain, weight, sex,
and genetic modification factors will be extracted.
The exact protocol for haemorrhagic shock will be
extracted, including volume of blood, percentage of
blood, as well as the timings of shock and intervention.
Techniques, equipment, and measurements of measuring
the microcirculatory parameters will be extracted, in-
cluding anatomical region.
Intervention characteristics
Type of fluid (e.g. red blood cells, whole blood,
altered blood, plasma, platelets, crystalloid, and col-
loid fluids) will be extracted, as well as volume, rate,
and timings.
Outcome measures
All findings relating to microcirculatory parameters
will be extracted, as well as physiological parameters
such as mean arterial pressure, blood pressure, and
heart rate.
Other parameters
Number of deaths, dropouts, and incomplete experi-
ments will also be extracted.
Assessment of risk of bias and study quality
Reviewers and discrepancies
Risk of bias will be assessed by two authors. Discrepancy
between authors will be resolved by discussion or by
referring to a third until consensus achieved.
Study assessment
Animal intervention studies will assessed using the
Systematic Review Centre for Laboratory animal Experi-
mentation (SYRCLE) risk of bias tool, which includes
domains for selection bias (sequence generation, baseline
characteristics, allocation concealment), performance
bias (random housing and blinding), detection bias
(random outcome assessment and blinding), attrition
bias, reporting bias, and other biases [9]. Case series
will be assessed based on the criteria proposed by
Moga et al. and tailored as appropriate to the subject
area [10].
Attention will also be paid towards the validity of
design and conduct of the studies and the
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translatability to humans, according to the summary
domains highlighted by Henderson et al. following their
examination of 26 separate guidelines [11]. This will be
discussed in depth following analysis of the data extracted.
Collection of outcome data
Type of outcome data to be extracted
Outcome data, units, and type (continuous/dichotomous)
will be as follows:
 Blood flow (nL/s); continuous data
 Red cell velocity (mm/s); continuous data
 Wall shear rate (s−1); continuous data
 Glycocalyx and vessel thickness (μm); continuous data
 Microvascular permeability (%); continuous data
 Functional capillary density (%); continuous data
 Perfused microvessel density (n/mm); continuous data
 Proportion of perfused vessels (%); continuous data
Method of data extraction
Primary method for data extraction will be taking the
numerical values directly from the results sections and
tables of individual studies. The three values of interest
for each outcome are the mean, standard deviation (SD),
and number of animals (N).
Where only percentages are reported in the place of
raw numerical data, the numerical values will be
calculated based on the reported percentage and
denominator. Where a numerical value is missing but
the data is displayed graphically, a digital screen ruler
will be used to extract the numerical data. Authors
will be contacted where these techniques are not
possible.
Reviewers and discrepancies
Outcome data extraction will be performed by one
reviewer and checked by a second.
Data analysis and synthesis
Combining and comparing the data
A combination of meta-analysis and descriptive tech-
niques will be used to report the outcome data. The
technique used will depend on the homogeneity and
number of studies that can be feasibly pooled together
for synthesis. Meta-analysis will be conducted using
Stata data analysis software (V14, StataCorp LP). Where
a number of similar studies (in terms of animal model,
intervention and outcomes) are reported by the same
study group or authors over time, authors will be
contacted to determine whether studies are independent
or include previously reported data.
Feasibility of meta-analysis
An assessment of clinical and methodological hetero-
geneity will be undertaken in order to inform a decision
on whether to pool data. Studies will be considered
homogeneous if they have a similar model of haemor-
rhagic shock, use similar methods in measuring the
microcirculatory parameters, test the same interven-
tions, and measure the same outcomes.
Where studies are considered too heterogeneous to
pool, synthesis will be narrative, and forest plots may
be used for illustration of heterogeneity without
pooling.
Effect measures
All of the outcomes of interest are continuous vari-
ables but may have been measured using different
instruments and in different sizes of animals. Where
it is not possible to pool results using the mean
difference, the normalised mean difference (NMD)
and standard deviation will be used in meta-analysis
as described by Vesterinen et al. [12].
The actual effect size in animal studies does not
necessarily translate to humans. Therefore, rather than
concentrate on the actual size of effect, emphasis will be
placed on the direction and consistency of effect, and
exploration of any heterogeneity.
Statistical modelling
Preliminary searches have demonstrated a relatively high
level of heterogeneity between studies. Underlying effect
size is likely to differ between studies even where there is
a degree of methodological homogeneity. Therefore,
where meta-analysis is used, random effects modelling
will be utilised in order to measure the mean of a
distribution of effects and to account for residual
heterogeneity.
Statistical methods to assess heterogeneity
The presence of heterogeneity will be assessed by visual
inspection of forest plots, as well as with the chi-
squared statistic. The I2 statistic will be used to quantify
the percentage of variability due to heterogeneity.
Heterogeneity will be categorised as suggested in the
Cochrane guidelines (http://handbook.cochrane.org) as
unimportant (0–40 %); moderate (30–60 %); substantial
(50–90 %), and considerable (75–100 %).
Subgroup analysis
Subgroup analysis will be performed for each inter-
vention (i.e. whole blood, PRBC, plasma, colloid,
crystalloid, altered blood products). Further subgroup
analysis of different species of animal and different
outcome measures will be conducted. The findings
from subgroup analyses will be interpreted cautiously
Naumann et al. Systematic Reviews  (2015) 4:135 Page 5 of 7
and used for generating hypotheses only, rather than
drawing more general conclusions. Appropriate ca-
veats will be made when reporting these results, and
p values will not be used.
Sensitivity analysis
Issues that require sensitivity analysis include the age of
study, as well as only including studies that were at low
risk of bias according to the SYRCLE risk of bias tool.
Other sensitivity analyses may relate to which analysis
methods were used (e.g. change in values versus final
values for continuous data or based on how missing data
had been handled).
Other meta-analysis details
In addition to pairwise meta-analysis of individual inter-
ventions versus control, further multi-treatment meta-
analysis will be performed for simultaneous comparison
of multiple interventions, as described by Caldwell et al.
[13]. The multiple interventions to be compared will
include PRBC versus crystalloid versus colloid.
Publication bias
Publication bias may be a particular risk with pre-
clinical/animal studies [14, 15]. For each meta-analysis
containing 20 or more studies, the likelihood of
publication bias will be investigated through the con-
struction of funnel plots and appropriate statistical
tests for small-study effects (such as the Peter’s Test
[16]), that is, the tendency for smaller studies to
provide more positive findings. It is well-recognised
that, especially where heterogeneity exists, publication
bias may be one of a number of reasons for any
small-study effects identified.
Discussion
The optimal volume, ratios, type, sequence of delivery,
and timing of resuscitation fluids following haemor-
rhagic shock of trauma remain controversial. Low vol-
ume resuscitation has been advocated following trauma
in order to reduce haemodilation and the effects of
trauma-induced coagulopathy [17]. However, strategies
which aim for a certain mean arterial pressure or which
utilise ‘permissive hypotension’ may not take into
account the significance of the physical dynamics of the
microcirculatory oxygen exchange surface. Since the
primary aims of resuscitation following haemorrhagic
shock are to restore tissue oxygenation, repay oxygen
debt, and reduce acidosis, it is the microcirculation that
is the key ‘target organ’ in this process. It is possible that
the monitoring of the function of the microcirculation
may have a role in the future as a means by which resus-
citation can be optimised [18].
In order to plan and conduct clinical investigation of
the microcirculation following haemorrhagic shock and
fluid resuscitation, it is first advisable to examine all the
available pre-clinical evidence. This may enable greater
focus and attention towards certain avenues and re-
search questions of interest. This systematic review will
examine the pre-clinical evidence available with regard
to microcirculatory function following resuscitation in
the context of haemorrhagic shock and will propose
clinical questions of interest based on the findings.
Additional file
Additional file 1: Sample search strategy in MEDLINE. This search
strategy was used to obtain the details for potentially relevent studies of
interest.
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